We’re on-site at the 2024 European Academy of Neurology Congress. Visit us at booth E10 to connect and learn more about our commitment to #ParkinsonsDisease. To learn more about MTPA’s plans at EAN, visit: https://bit.ly/3VDmDMy
Mitsubishi Tanabe Pharma America’s Post
More Relevant Posts
-
🚨 Looking Forward To Seeing Everyone In Denver For #AAN. Be Sure To Stop By To Say Hi, and See Our Comprehensive #Neurodiagnostic Portfolio!! 🚨 #Neurology #EEG #Epilepsy
Our team is looking forward to the upcoming American Academy of Neurology annual meeting. April 13-18th in Denver. Stop by Booth #888 to see all of our Neuro-Diagnostic Solutions, including Okti. Everything you want. Simple. Portable. Wireless and High Definition. https://lnkd.in/ekmtNCMn
To view or add a comment, sign in
-
Prof Urs Fischer, Chairman of the Department of Neurology at the University of Basel, has provided an initial insight into the findings of the SWITCH Trial. This pivotal research addresses the significant challenge of treating intracerebral hemorrhage within the field of stroke medicine. "To SWITCH, or not to SWITCH, that is the question." We can't wait to hear more at #ESOC2024. There is still time to register for the conference: https://ow.ly/j2uG50Ryb2u #stroke #strokeresearch #strokescience #strokecare #voiceofstroke
To view or add a comment, sign in
-
In this MEDtalk, Jennifer Spillane, a neurology consultant from the Queen Square, the National Hospital for Neurology, and Guys and St. Thomas', discusses data from the UK's Early Access to Medicine Scheme for efgartigimod, a treatment for myasthenia gravis. Jennifer highlights the data collection process, patient characteristics, treatment outcomes, and the overall efficacy and safety of efgartigimod. 🔗Follow along as we cover the EAN 2024 congress; https://lnkd.in/dmWquMkt #EAN24 #MyastheniaGravis
To view or add a comment, sign in
-
Save on Functional Neurology Management of Concussion Level 1 and Concussion Bootcamp in honor of #braininjuryawarenessmonth! To learn more and save, visit - https://lnkd.in/ewdg8rT8
To view or add a comment, sign in
-
In this MEDtalk, Jennifer Spillane, a neurology consultant from the Queen Square, the National Hospital for Neurology, and Guys and St. Thomas', discusses data from the UK's Early Access to Medicine Scheme for efgartigimod, a treatment for myasthenia gravis. Jennifer highlights the data collection process, patient characteristics, treatment outcomes, and the overall efficacy and safety of efgartigimod. 🔗Follow along as we cover the EAN 2024 congress; https://lnkd.in/dzTEGiny #EAN24 #MyastheniaGravis
Efgartigimod is Safe and Effective in Previously Refractory AChR Myasthenia Gravis Patients
https://bpno.no
To view or add a comment, sign in
-
In this MEDtalk, Jennifer Spillane, a neurology consultant from the Queen Square, the National Hospital for Neurology, and Guys and St. Thomas', discusses data from the UK's Early Access to Medicine Scheme for efgartigimod, a treatment for myasthenia gravis. Jennifer highlights the data collection process, patient characteristics, treatment outcomes, and the overall efficacy and safety of efgartigimod. 🔗Follow along as we cover the EAN 2024 congress; https://lnkd.in/dz9VJRPC #EAN24 #MyastheniaGravis
Efgartigimod is Safe and Effective in Previously Refractory AChR Myasthenia Gravis Patients
https://bpno.fi
To view or add a comment, sign in
-
Save on Functional Neurology Management of Concussion Level 1 and Concussion Bootcamp in honor of #braininjuryawarenessmonth! To learn more and save, visit - https://lnkd.in/ewdg8rT8
To view or add a comment, sign in
-
In a recent episode of NeurologyLive Insights, Richard Lewis, MD, professor of neurology at Cedars-Sinai Medical Center, gives a comprehensive overview of #CIDP and describes the most common symptoms seen in patients. View the full episode here: https://lnkd.in/e-8uxX7a
To view or add a comment, sign in
-
In this MEDtalk, Jennifer Spillane, a neurology consultant from the Queen Square, the National Hospital for Neurology, and Guys and St. Thomas', discusses data from the UK's Early Access to Medicine Scheme for efgartigimod, a treatment for myasthenia gravis. Jennifer highlights the data collection process, patient characteristics, treatment outcomes, and the overall efficacy and safety of efgartigimod. 🔗Follow along as we cover the EAN 2024 congress; https://lnkd.in/dV62Xfaq #EAN24 #MyastheniaGravis
Efgartigimod is Safe and Effective in Previously Refractory AChR Myasthenia Gravis Patients
https://bpno.dk
To view or add a comment, sign in
-
Time is crucial when someone is experiencing a stroke. Dr. Venizelos, Medical Director of Endovascular Neurology at Summa Health, is here to provide education on strokes, from what it is, to warning signs, treatment options and more. #StrokeAwarenessMonth
Medical Minute with Dr. Venizelos
To view or add a comment, sign in
14,860 followers